DXT: Injector And Syringe, Angiographic

Product code DXT, “Injector And Syringe, Angiographic” in FDA's classification database, is a Class II device type under 21 CFR 870.1650 (angiographic injector and syringe), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 211 clearances under DXT, 64 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
DXT
Regulation
21 CFR 870.1650
Class
II
Panel
Cardiovascular
Clearances
211
Most recent
Oct 6, 2026
Median review, last 2 years
249 days
Third-party review
Eligible
Implant
No

What it covers

An angiographic injector and syringe is a device that consists of a syringe and a high-pressure injector which are used to inject contrast material into the heart, great vessels, and coronary arteries to study the heart and vessels by x-ray photography.

The identification in 21 CFR 870.1650, angiographic injector and syringe. FDA gives DXT no definition of its own, so the regulation’s describes it.

Recent clearances

510(k)DeviceApplicantDecisionType
K262043MEDRAD® MRXperion MR Injection System and MR Injection System Syringe Kit; MEDRAD® IS12 Module (IS12); MEDRAD® Imaging Bulk Package Transfer SpikeBayer Medical Care, Inc.Oct 6, 2026Traditional
K252652Disposable Syringes with Accessories for Power Injectors (900103T); Disposable Syringes with Accessories for Power Injectors (900103H); Disposable Syringes with Accessories for Power Injectors (801800H); Disposable Syringes with Accessories for Power Injectors (800099T); Disposable Syringes with Accessories for Power Injectors (800099H); Disposable Syringes with Accessories for Power Injectors (800096T); Disposable Syringes with Accessories for Power Injectors (800096H); Disposable SyrFortis Biosolutions Company LimitedMay 14, 2026Traditional
K252638VeraPro S100 Multi-Use Syringe (018808); VeraPro S100 LV1 Low Viscosity Single-Use Syringe (018811); VeraPro AMT Auto-Manifold and Transducer (018814); VeraPro AngioTouch FLX165 Hand Controller Kit (018806); VeraPro AngioTouch HiFi165 Hand Controller Kit (018804)Acist Medical Systems, Inc.May 13, 2026Traditional
K252653ACIST Pro Diagnostic System (019304); Processing Unit Bed Mount; AngioTouch Module; ACIST Pro Cart; Single Transducer Cable; Triple Transducer CableAcist Medical Systems, Inc.May 13, 2026Traditional
K253048High Pressure Syringe; Pressure Connecting Tube; Quick fill tube; Spike; Transfer TubeShenzhen Maiwei Biotech Co., Ltd.Apr 16, 2026Traditional
K251788Extension tubeZhuhai DR Medical Instruments Co., Ltd.Mar 5, 2026Traditional
K252891MEDRAD MRXperion MR Injection System and MR Injection System Syringe Kit; MEDRAD ISI2 Module (ISI2)Bayer Medical Care, Inc.Feb 13, 2026Traditional
K244038High Pressure TubingShandong Int Medical Instruments Co., Ltd.Sep 5, 2025Traditional
K242143Angiography InjectorShandong Int Medical Instruments Co., Ltd.Dec 23, 2024Traditional
K242212Disposable Syringe (Kit); Nemoto Disposable Syringe (Kit)Nemoto Kyorindo Co., Ltd.Aug 27, 2024Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 211 with a free account)

Clearances by year

64 DXT 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)7264
20251249
20244138
20231104
20211152
20203154
2019496
2018993
20177183
20168172
20157153
20146144
20132265
2011469

Who submits

26 applicants cleared a DXT device since 2011. 70% of the clearances went to applicants in United States, then China (23%), Japan (5%) and Taiwan (2%). By type: Traditional 73%, Special 25% and Abbreviated 2%. 2 went through a third-party review organization.

ApplicantClearances since 2011
Osprey Medical, Inc.14
Bayer Medical Care, Inc.8
Coeur, Inc.7
Acist Medical Systems, Inc.5
Nemoto Kyorindo Co., Ltd.3
Shenzhen Boon Medical Supply Co., Ltd.3
Medrad, Inc.2
Merit Medical Systems, Inc.2

How FDA classifies it

Class II (special controls). The device, when it is a non-patient contacting balloon inflation syringe intended only to inflate/deflate balloon catheters and monitor pressure within the balloon, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.

From 21 CFR 870.1650. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 870.1650 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent DXT clearances declared.

Ask about DXT

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about DXT

What is FDA product code DXT?

Product code DXT, “Injector And Syringe, Angiographic” in FDA's classification database, is a Class II device type under 21 CFR 870.1650 (angiographic injector and syringe), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 211 clearances under DXT, 64 of them since 2011.

How many 510(k) clearances are there under DXT?

FDA’s 510(k) database listed 211 clearances under DXT as of Oct 29, 2026, 64 of them decided since 2011; the most recent decision was Oct 6, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a DXT 510(k)?

For the 9 DXT clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 249 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most DXT clearances?

Since 2011: Osprey Medical, Inc. (14), Bayer Medical Care, Inc. (8), Coeur, Inc. (7), Acist Medical Systems, Inc. (5) and Nemoto Kyorindo Co., Ltd. (3). 26 applicants have cleared a DXT device in that time.

Sources

  1. FDA product classification: DXT · Product Classification database
  2. 21 CFR 870.1650: Angiographic injector and syringe · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for DXT · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow DXTGet an email when FDA clears, recalls or publishes guidance for DXT devices.

Know what FDA already cleared.